Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

c-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration.

Aquila I, Cianflone E, Scalise M, Marino F, Mancuso T, Filardo A, Smith AJ, Cappetta D, De Angelis A, Urbanek K, Isidori AM, Torella M, Agosti V, Viglietto G, Nadal-Ginard B, Ellison-Hughes GM, Torella D.

Cell Death Dis. 2019 Jun 4;10(6):436. doi: 10.1038/s41419-019-1655-5.

2.

Identification of mesothelial cells in intraoperative blood salvage.

Santise G, Maselli D, Malanga D, Di Vito A, Mandarino N, Boccadamo G, Zeppa P, Amorosi A, Viglietto G, Rizzuto A, Mignogna C.

Am J Transl Res. 2019 Mar 15;11(3):1771-1779. eCollection 2019.

3.

Retraction: Haploinsufficiency of the Hmga1 Gene Causes Cardiac Hypertrophy and Myelo-Lymphoproliferative Disorders in Mice.

Fedele M, Fidanza V, Battista S, Pentimalli F, Klein-Szanto AJP, Visone R, De Martino I, Curcio A, Morisco C, Del Vecchio L, Baldassarre G, Arra C, Viglietto G, Indolfi C, Croce CM, Fusco A.

Cancer Res. 2018 Dec 15;78(24):6908. doi: 10.1158/0008-5472.CAN-18-3457. No abstract available.

PMID:
30552126
4.

Retraction: The Receptor-Type Protein Tyrosine Phosphatase J Antagonizes the Biochemical and Biological Effects of RET-Derived Oncoproteins.

Iervolino A, Iuliano R, Trapasso F, Viglietto G, Melillo RM, Carlomagno F, Santoro M, Fusco A.

Cancer Res. 2018 Dec 15;78(24):6907. doi: 10.1158/0008-5472.CAN-18-3456. No abstract available.

PMID:
30552125
5.

Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b/p53 axis.

Biamonte F, Battaglia AM, Zolea F, Oliveira DM, Aversa I, Santamaria G, Giovannone ED, Rocco G, Viglietto G, Costanzo F.

Cell Death Dis. 2018 Dec 5;9(12):1174. doi: 10.1038/s41419-018-1216-3.

6.

The T197A Knock-in Model of Cdkn1b Gene to Study the Effects of p27 Restoration In Vivo.

De Marco C, Rinaldo N, De Vita F, Forzati F, Caira E, Iovane V, Paciello O, Montanaro D, D'Andrea S, Baldassarre G, Papparella S, Malanga D, Baldi A, Viglietto G.

Mol Cancer Ther. 2019 Feb;18(2):482-493. doi: 10.1158/1535-7163.MCT-18-0134. Epub 2018 Nov 13.

PMID:
30425132
7.

Correction to: Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene.

Oliveira DM, Grillone K, Mignogna C, De Falco V, Laudanna C, Biamonte F, Locane R, Corcione F, Fabozzi M, Sacco R, Viglietto G, Malanga D, Rizzuto A.

J Exp Clin Cancer Res. 2018 Jun 1;37(1):112. doi: 10.1186/s13046-018-0776-5.

8.

Simultaneous identification of clinically relevant single nucleotide variants, copy number alterations and gene fusions in solid tumors by targeted next-generation sequencing.

Oliveira DM, Mirante T, Mignogna C, Scrima M, Migliozzi S, Rocco G, Franco R, Corcione F, Viglietto G, Malanga D, Rizzuto A.

Oncotarget. 2018 Apr 27;9(32):22749-22768. doi: 10.18632/oncotarget.25229. eCollection 2018 Apr 27.

9.

Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing.

Oliveira DM, Laudanna C, Migliozzi S, Zoppoli P, Santamaria G, Grillone K, Elia L, Mignogna C, Biamonte F, Sacco R, Corcione F, Viglietto G, Malanga D, Rizzuto A.

Oncotarget. 2018 May 8;9(35):23960-23974. doi: 10.18632/oncotarget.25251. eCollection 2018 May 8.

10.

Centrosome Linker-induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers.

Remo A, Manfrin E, Parcesepe P, Ferrarini A, Han HS, Mickys U, Laudanna C, Simbolo M, Malanga D, Oliveira DM, Baritono E, Colangelo T, Sabatino L, Giuliani J, Molinari E, Garonzi M, Xumerle L, Delledonne M, Giordano G, Ghimenton C, Lonardo F, D'angelo F, Grillo F, Mastracci L, Viglietto G, Ceccarelli M, Colantuoni V, Scarpa A, Pancione M.

Mol Cancer Res. 2018 Sep;16(9):1385-1395. doi: 10.1158/1541-7786.MCR-18-0062. Epub 2018 May 21.

PMID:
29784668
11.

Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data.

Oliveira DM, Santamaria G, Laudanna C, Migliozzi S, Zoppoli P, Quist M, Grasso C, Mignogna C, Elia L, Faniello MC, Marinaro C, Sacco R, Corcione F, Viglietto G, Malanga D, Rizzuto A.

Oncotarget. 2018 Apr 17;9(29):20409-20425. doi: 10.18632/oncotarget.24912. eCollection 2018 Apr 17.

12.

Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene.

Mendes Oliveira D, Grillone K, Mignogna C, De Falco V, Laudanna C, Biamonte F, Locane R, Corcione F, Fabozzi M, Sacco R, Viglietto G, Malanga D, Rizzuto A.

J Exp Clin Cancer Res. 2018 Apr 17;37(1):84. doi: 10.1186/s13046-018-0746-y. Erratum in: J Exp Clin Cancer Res. 2018 Jun 1;37(1):112.

13.

Retraction for Melillo et al., "Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation".

Melillo RM, Pierantoni GM, Scala S, Battista S, Fedele M, Stella A, De Biasio MC, Chiappetta G, Fidanza V, Condorelli G, Santoro M, Croce CM, Viglietto G, Fusco A.

Mol Cell Biol. 2018 Feb 27;38(6). pii: e00660-17. doi: 10.1128/MCB.00660-17. Print 2018 Mar 15. No abstract available.

14.

Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.

Aversa I, Zolea F, Ieranò C, Bulotta S, Trotta AM, Faniello MC, De Marco C, Malanga D, Biamonte F, Viglietto G, Cuda G, Scala S, Costanzo F.

J Exp Clin Cancer Res. 2017 Aug 3;36(1):104. doi: 10.1186/s13046-017-0571-8.

15.

Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.

De Marco C, Laudanna C, Rinaldo N, Oliveira DM, Ravo M, Weisz A, Ceccarelli M, Caira E, Rizzuto A, Zoppoli P, Malanga D, Viglietto G.

PLoS One. 2017 Jun 29;12(6):e0178865. doi: 10.1371/journal.pone.0178865. eCollection 2017.

16.

Aberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients.

Scrima M, Zito Marino F, Oliveira DM, Marinaro C, La Mantia E, Rocco G, De Marco C, Malanga D, De Rosa N, Rizzuto A, Botti G, Franco R, Zoppoli P, Viglietto G.

J Cancer. 2017 Jan 15;8(2):227-239. doi: 10.7150/jca.17093. eCollection 2017.

17.

MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer.

Minciacchi VR, Spinelli C, Reis-Sobreiro M, Cavallini L, You S, Zandian M, Li X, Mishra R, Chiarugi P, Adam RM, Posadas EM, Viglietto G, Freeman MR, Cocucci E, Bhowmick NA, Di Vizio D.

Cancer Res. 2017 May 1;77(9):2306-2317. doi: 10.1158/0008-5472.CAN-16-2942. Epub 2017 Feb 15. Erratum in: Cancer Res. 2017 Jul 15;77(14 ):3961.

18.

Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.

Guerriero I, D'Angelo D, Pallante P, Santos M, Scrima M, Malanga D, De Marco C, Ravo M, Weisz A, Laudanna C, Ceccarelli M, Falco G, Rizzuto A, Viglietto G.

Oncotarget. 2017 Mar 21;8(12):19172-19191. doi: 10.18632/oncotarget.13432.

19.

High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients.

Conley A, Minciacchi VR, Lee DH, Knudsen BS, Karlan BY, Citrigno L, Viglietto G, Tewari M, Freeman MR, Demichelis F, Di Vizio D.

RNA Biol. 2017 Mar 4;14(3):305-316. doi: 10.1080/15476286.2016.1259061. Epub 2016 Nov 18.

20.

IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells.

Fiume G, Scialdone A, Rizzo F, De Filippo MR, Laudanna C, Albano F, Golino G, Vecchio E, Pontoriero M, Mimmi S, Ceglia S, Pisano A, Iaccino E, Palmieri C, Paduano S, Viglietto G, Weisz A, Scala G, Quinto I.

Int J Mol Sci. 2016 Nov 7;17(11). pii: E1848.

21.

The rat tyrosine phosphatase η increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.

Le Pera I, Iuliano R, Florio T, Susini C, Trapasso F, Santoro M, Chiariotti L, Schettini G, Viglietto G, Fusco A.

Oncogene. 2016 Oct 13;35(41):5456. doi: 10.1038/onc.2016.138. Epub 2016 Jul 18. No abstract available.

PMID:
27425594
22.

Circulating non-hematological cells during cardiopulmonary bypass: new findings in cardiac surgery procedures.

Santise G, Marinaro C, Maselli D, Dominici C, Di Vito A, Donato G, Camastra C, Zeppa P, Barni T, Rizzuto A, Viglietto G, Mignogna C.

Perfusion. 2016 Oct;31(7):584-92. doi: 10.1177/0267659116638916. Epub 2016 Mar 21.

PMID:
27000150
23.

AKT1E¹⁷K Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer.

Malanga D, Belmonte S, Colelli F, Scarfò M, De Marco C, Oliveira DM, Mirante T, Camastra C, Gagliardi M, Rizzuto A, Mignogna C, Paciello O, Papparella S, Fagman H, Viglietto G.

PLoS One. 2016 Feb 9;11(2):e0147334. doi: 10.1371/journal.pone.0147334. eCollection 2016.

24.

The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells.

Malanga D, De Marco C, Guerriero I, Colelli F, Rinaldo N, Scrima M, Mirante T, De Vitis C, Zoppoli P, Ceccarelli M, Riccardi M, Ravo M, Weisz A, Federico A, Franco R, Rocco G, Mancini R, Rizzuto A, Gulletta E, Ciliberto G, Viglietto G.

Oncotarget. 2015 Dec 15;6(40):42667-86. doi: 10.18632/oncotarget.5626.

25.

Mutant AKT1-E17K is oncogenic in lung epithelial cells.

De Marco C, Malanga D, Rinaldo N, De Vita F, Scrima M, Lovisa S, Fabris L, Carriero MV, Franco R, Rizzuto A, Baldassarre G, Viglietto G.

Oncotarget. 2015 Nov 24;6(37):39634-50. doi: 10.18632/oncotarget.4022.

26.

Homeodomain-interacting protein kinase-2 stabilizes p27kip1 by its phosphorylation at serine 10 and contributes to cell motility.

Pierantoni GM, Esposito F, Tornincasa M, Rinaldo C, Viglietto G, Soddu S, Fusco A.

J Biol Chem. 2014 Jun 20;289(25):17426. doi: 10.1074/jbc.A111.230854. No abstract available.

27.

Identification of H ferritin-dependent and independent genes in K562 differentiating cells by targeted gene silencing and expression profiling.

Misaggi R, Di Sanzo M, Cosentino C, Bond HM, Scumaci D, Romeo F, Stellato C, Giurato G, Weisz A, Quaresima B, Barni T, Amato F, Viglietto G, Morrone G, Cuda G, Faniello MC, Costanzo F.

Gene. 2014 Feb 10;535(2):327-35. doi: 10.1016/j.gene.2013.10.067. Epub 2013 Nov 14.

PMID:
24239552
28.

Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair.

Ellison GM, Vicinanza C, Smith AJ, Aquila I, Leone A, Waring CD, Henning BJ, Stirparo GG, Papait R, Scarfò M, Agosti V, Viglietto G, Condorelli G, Indolfi C, Ottolenghi S, Torella D, Nadal-Ginard B.

Cell. 2013 Aug 15;154(4):827-42. doi: 10.1016/j.cell.2013.07.039.

29.

Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma.

De Marco C, Rinaldo N, Bruni P, Malzoni C, Zullo F, Fabiani F, Losito S, Scrima M, Marino FZ, Franco R, Quintiero A, Agosti V, Viglietto G.

PLoS One. 2013;8(2):e55362. doi: 10.1371/journal.pone.0055362. Epub 2013 Feb 7.

30.

Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells.

van den Boom V, Rozenveld-Geugien M, Bonardi F, Malanga D, van Gosliga D, Heijink AM, Viglietto G, Morrone G, Fusetti F, Vellenga E, Schuringa JJ.

Blood. 2013 Mar 28;121(13):2452-61. doi: 10.1182/blood-2012-08-451666. Epub 2013 Jan 24.

31.

Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity.

Paduano F, Ortuso F, Campiglia P, Raso C, Iaccino E, Gaspari M, Gaudio E, Mangone G, Carotenuto A, Bilotta A, Narciso D, Palmieri C, Agosti V, Artese A, Gomez-Monterrey I, Sala M, Cuda G, Iuliano R, Perrotti N, Scala G, Viglietto G, Alcaro S, Croce CM, Novellino E, Fusco A, Trapasso F.

ACS Chem Biol. 2012 Oct 19;7(10):1666-76. doi: 10.1021/cb300281t. Epub 2012 Jul 10.

PMID:
22759068
32.

PKC-dependent phosphorylation of p27 at T198 contributes to p27 stabilization and cell cycle arrest.

De Vita F, Riccardi M, Malanga D, Scrima M, De Marco C, Viglietto G.

Cell Cycle. 2012 Apr 15;11(8):1583-92. doi: 10.4161/cc.20003. Epub 2012 Apr 15.

PMID:
22441823
33.

Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase.

Scrima M, De Marco C, Fabiani F, Franco R, Pirozzi G, Rocco G, Ravo M, Weisz A, Zoppoli P, Ceccarelli M, Botti G, Malanga D, Viglietto G.

PLoS One. 2012;7(2):e30427. doi: 10.1371/journal.pone.0030427. Epub 2012 Feb 17.

34.

The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.

Scrima M, De Marco C, De Vita F, Fabiani F, Franco R, Pirozzi G, Rocco G, Malanga D, Viglietto G.

Am J Pathol. 2012 Mar;180(3):1202-14. doi: 10.1016/j.ajpath.2011.11.038. Epub 2012 Jan 13.

PMID:
22245727
35.

Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.

Malanga D, De Gisi S, Riccardi M, Scrima M, De Marco C, Robledo M, Viglietto G.

Eur J Endocrinol. 2012 Mar;166(3):551-60. doi: 10.1530/EJE-11-0929. Epub 2011 Nov 30.

PMID:
22129891
36.

H ferritin gene silencing in a human metastatic melanoma cell line: a proteomic analysis.

Di Sanzo M, Gaspari M, Misaggi R, Romeo F, Falbo L, De Marco C, Agosti V, Quaresima B, Barni T, Viglietto G, Larsen MR, Cuda G, Costanzo F, Faniello MC.

J Proteome Res. 2011 Dec 2;10(12):5444-53. doi: 10.1021/pr200705z. Epub 2011 Nov 14.

PMID:
22043922
37.

BRCA1 is required for hMLH1 stabilization following doxorubicin-induced DNA damage.

Romeo F, Falbo L, Di Sanzo M, Misaggi R, Faniello MC, Viglietto G, Cuda G, Costanzo F, Quaresima B.

Int J Biochem Cell Biol. 2011 Dec;43(12):1754-63. doi: 10.1016/j.biocel.2011.08.011. Epub 2011 Aug 16.

PMID:
21864706
38.

Negative transcriptional regulation of the human periostin gene by YingYang-1 transcription factor.

Romeo F, Falbo L, Di Sanzo M, Misaggi R, Faniello MC, Barni T, Cuda G, Viglietto G, Santoro C, Quaresima B, Costanzo F.

Gene. 2011 Nov 10;487(2):129-34. doi: 10.1016/j.gene.2011.07.025. Epub 2011 Aug 3.

PMID:
21839814
39.

Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment.

Mancini R, Giarnieri E, De Vitis C, Malanga D, Roscilli G, Noto A, Marra E, Laudanna C, Zoppoli P, De Luca P, Affuso A, Ruco L, Di Napoli A, Mesiti G, Aurisicchio L, Ricci A, Mariotta S, Pisani L, Andreetti C, Viglietto G, Rendina EA, Giovagnoli MR, Ciliberto G.

PLoS One. 2011;6(7):e21320. doi: 10.1371/journal.pone.0021320. Epub 2011 Jul 18.

40.

Homeodomain-interacting protein kinase-2 stabilizes p27(kip1) by its phosphorylation at serine 10 and contributes to cell motility.

Pierantoni GM, Esposito F, Tornincasa M, Rinaldo C, Viglietto G, Soddu S, Fusco A.

J Biol Chem. 2011 Aug 19;286(33):29005-13. doi: 10.1074/jbc.M111.230854. Epub 2011 Jun 29. Retraction in: J Biol Chem. 2014 Jun 20;289(25):17426.

41.

Contribution of PKB/AKT signaling to thyroid cancer.

Viglietto G, Amodio N, Malanga D, Scrima M, De Marco C.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1461-87. Review.

PMID:
21196242
42.

VEGA: variational segmentation for copy number detection.

Morganella S, Cerulo L, Viglietto G, Ceccarelli M.

Bioinformatics. 2010 Dec 15;26(24):3020-7. doi: 10.1093/bioinformatics/btq586. Epub 2010 Oct 19.

PMID:
20959380
43.

Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.

Amodio N, Scrima M, Palaia L, Salman AN, Quintiero A, Franco R, Botti G, Pirozzi P, Rocco G, De Rosa N, Viglietto G.

Am J Pathol. 2010 Nov;177(5):2622-34. doi: 10.2353/ajpath.2010.091075. Epub 2010 Oct 1.

44.

Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs.

Cioce M, Gherardi S, Viglietto G, Strano S, Blandino G, Muti P, Ciliberto G.

Cell Cycle. 2010 Jul 15;9(14):2878-87. Epub 2010 Jul 13.

PMID:
20581442
45.

Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.

Landa I, Montero-Conde C, Malanga D, De Gisi S, Pita G, Leandro-García LJ, Inglada-Pérez L, Letón R, De Marco C, Rodríguez-Antona C, Viglietto G, Robledo M.

Endocr Relat Cancer. 2010 Jun 1;17(2):317-28. doi: 10.1677/ERC-09-0016. Print 2010 Jun.

PMID:
20075119
46.

An interview with Dr. Giuseppe Viglietto on his highly cited paper published in Cell Cycle.

Viglietto G.

Cell Cycle. 2009 Sep 15;8(18):2869-70. No abstract available.

PMID:
19757507
47.

Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung.

Viglietto G.

Cell Cycle. 2009 Sep;8(18):2869-2870. Epub 2009 Sep 9. No abstract available.

PMID:
19736514
48.

The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.

Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, Viglietto G, Rocco G, Pirozzi G.

Eur J Cardiothorac Surg. 2009 Sep;36(3):446-53. doi: 10.1016/j.ejcts.2009.03.063. Epub 2009 May 22.

PMID:
19464919
49.

Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice.

Fedele M, Palmieri D, Chiappetta G, Pasquinelli R, De Martino I, Arra C, Palma G, Valentino T, Pierantoni GM, Viglietto G, Rothstein JL, Santoro M, Fusco A.

Endocr Relat Cancer. 2009 Jun;16(2):483-90. doi: 10.1677/ERC-08-0272. Epub 2009 Mar 4.

PMID:
19261681
50.

The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization.

Iuliano R, Raso C, Quintiero A, Pera IL, Pichiorri F, Palumbo T, Palmieri D, Pattarozzi A, Florio T, Viglietto G, Trapasso F, Croce CM, Fusco A.

J Biochem. 2009 Mar;145(3):377-85. doi: 10.1093/jb/mvn175. Epub 2009 Jan 3.

PMID:
19122201

Supplemental Content

Loading ...
Support Center